Literature DB >> 16251901

Haplotype block structure study of the CFTR gene. Most variants are associated with the M470 allele in several European populations.

Fiorenza Pompei1, Bianca Maria Ciminelli, Cristina Bombieri, Cinzia Ciccacci, Monika Koudova, Silvia Giorgi, Francesca Belpinati, Angela Begnini, Milos Cerny, Marie Des Georges, Mireille Claustres, Claude Ferec, Milan Macek, Guido Modiano, Pier Franco Pignatti.   

Abstract

An average of about 1700 CFTR (cystic fibrosis transmembrane conductance regulator) alleles from normal individuals from different European populations were extensively screened for DNA sequence variation. A total of 80 variants were observed: 61 coding SNSs (results already published), 13 noncoding SNSs, three STRs, two short deletions, and one nucleotide insertion. Eight DNA variants were classified as non-CF causing due to their high frequency of occurrence. Through this survey the CFTR has become the most exhaustively studied gene for its coding sequence variability and, though to a lesser extent, for its noncoding sequence variability as well. Interestingly, most variation was associated with the M470 allele, while the V470 allele showed an 'extended haplotype homozygosity' (EHH). These findings make us suggest a role for selection acting either on the M470V itself or through an hitchhiking mechanism involving a second site. The possible ancient origin of the V allele in an 'out of Africa' time frame is discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16251901     DOI: 10.1038/sj.ejhg.5201498

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  8 in total

Review 1.  Congenital bilateral absence of the vas deferens as an atypical form of cystic fibrosis: reproductive implications and genetic counseling.

Authors:  D A S de Souza; F R Faucz; L Pereira-Ferrari; V S Sotomaior; S Raskin
Journal:  Andrology       Date:  2017-12-07       Impact factor: 3.842

2.  The CFTR Met 470 allele is associated with lower birth rates in fertile men from a population isolate.

Authors:  Gülüm Kosova; Joseph K Pickrell; Joanna L Kelley; Patrick F McArdle; Alan R Shuldiner; Mark Abney; Carole Ober
Journal:  PLoS Genet       Date:  2010-06-03       Impact factor: 5.917

3.  Comparative analysis of common CFTR polymorphisms poly-T, TG-repeats and M470V in a healthy Chinese population.

Authors:  Qin Huang; Wei Ding; Mu-Xin Wei
Journal:  World J Gastroenterol       Date:  2008-03-28       Impact factor: 5.742

4.  Implications for health and disease in the genetic signature of the Ashkenazi Jewish population.

Authors:  Saurav Guha; Jeffrey A Rosenfeld; Anil K Malhotra; Annette T Lee; Peter K Gregersen; John M Kane; Itsik Pe'er; Ariel Darvasi; Todd Lencz
Journal:  Genome Biol       Date:  2012-01-25       Impact factor: 13.583

5.  A genome-wide approach to identify genetic loci with a signature of natural selection in the Irish population.

Authors:  Valeria Mattiangeli; Anthony W Ryan; Ross McManus; Daniel G Bradley
Journal:  Genome Biol       Date:  2006-08-11       Impact factor: 13.583

6.  Systematic estimation of cystic fibrosis prevalence in Chinese and genetic spectrum comparison to Caucasians.

Authors:  Qi Ni; Xiang Chen; Ping Zhang; Lin Yang; Yulan Lu; Feifan Xiao; Bingbing Wu; Huijun Wang; Wenhao Zhou; Xinran Dong
Journal:  Orphanet J Rare Dis       Date:  2022-03-21       Impact factor: 4.123

7.  The susceptibility of T5-TG12 of the CFTR gene in chronic bronchitis occurrence in a Chinese population in Jiangsu province, China.

Authors:  Ping Wang; Satoru Naruse; Hong Yin; Zhongfang Yu; Tianqu Zhuang; Wei Ding; Yanmin Wu; Muxin Wei
Journal:  J Biomed Res       Date:  2012-04-22

Review 8.  Mutations of the cystic fibrosis transmembrane conductance regulator gene in males with congenital bilateral absence of the vas deferens: Reproductive implications and genetic counseling (Review).

Authors:  Xiangrong Cui; Xueqing Wu; Qiang Li; Xuan Jing
Journal:  Mol Med Rep       Date:  2020-08-24       Impact factor: 2.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.